(Q39130536)

English

Pharmacokinetic and pharmacodynamic relationship of AMG 811, an anti-IFN-γ IgG1 monoclonal antibody, in patients with systemic lupus erythematosus

scientific article published on 12 September 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

9 September 2017

Pharmacokinetic and pharmacodynamic relationship of AMG 811, an anti-IFN-γ IgG1 monoclonal antibody, in patients with systemic lupus erythematosus (English)

1 reference

Europe PubMed Central

9 September 2017

1 reference

based on heuristic

inferred from title

systemic lupus erythematosus

0 references

monoclonal antibody

1 reference

based on heuristic

inferred from title

pharmacokinetics

1 reference

based on heuristic

inferred from title

pharmacodynamics

1 reference

based on heuristic

inferred from title

author name string

Ping Chen

1

1 reference

Europe PubMed Central

9 September 2017

Thuy Vu

2

1 reference

Europe PubMed Central

9 September 2017

Adimoolam Narayanan

3

1 reference

Europe PubMed Central

9 September 2017

Winnie Sohn

4

1 reference

Europe PubMed Central

9 September 2017

Jin Wang

5

1 reference

Europe PubMed Central

9 September 2017

Michael Boedigheimer

6

1 reference

Europe PubMed Central

9 September 2017

Andrew A Welcher

7

1 reference

Europe PubMed Central

9 September 2017

Barbara Sullivan

8

1 reference

Europe PubMed Central

9 September 2017

David A Martin

9

1 reference

Europe PubMed Central

9 September 2017

Juan Jose Perez Ruixo

10

1 reference

Europe PubMed Central

9 September 2017

Peiming Ma

11

1 reference

Europe PubMed Central

9 September 2017

publication date

12 September 2014

1 reference

Europe PubMed Central

9 September 2017

Pharmaceutical Research

1 reference

Europe PubMed Central

9 September 2017

32

1 reference

Europe PubMed Central

9 September 2017

2

1 reference

Europe PubMed Central

9 September 2017

640-653

1 reference

Europe PubMed Central

9 September 2017

Cellular responses to interferon-gamma

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

The role of IFN-gamma in systemic lupus erythematosus: a challenge to the Th1/Th2 paradigm in autoimmunity

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis, and other rheumatic diseases

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Serum soluble markers of immune activation and disease activity in systemic lupus erythematosus.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Role of guanylate binding protein-1 in vascular defects associated with chronic inflammatory diseases.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: a validation study

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

General pharmacokinetic model for drugs exhibiting target-mediated drug disposition

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Approximations of the target-mediated drug disposition model and identifiability of model parameters.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Likelihood based approaches to handling data below the quantification limit using NONMEM VI.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Building population pharmacokineticpharmacodynamic models. I. Models for covariate effects

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Exposure-response modeling of darbepoetin alfa in anemic patients with chronic kidney disease not receiving dialysis.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Mechanistic determinants of biotherapeutics absorption following SC administration.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Pharmacokinetic-pharmacodynamic-efficacy analysis of efalizumab in patients with moderate to severe psoriasis.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Population pharmacokinetics of therapeutic monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Population pharmacokinetic analysis of panitumumab in patients with advanced solid tumors

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Population pharmacokinetic analysis of tocilizumab in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Pharmacokinetic aspects of biotechnology products

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Elevated serum IL-6, IL-8, MCP-1, CRP, and IFN-γ levels in 10- to 11-year-old boys with increased BMI.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Handling data below the limit of quantification in mixed effect models

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Selection between Michaelis-Menten and target-mediated drug disposition pharmacokinetic models

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Theoretical considerations of target-mediated drug disposition models: simplifications and approximations

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Interferon-gamma pharmacokinetics and pharmacodynamics in patients with colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Gamma-interferon transcriptionally regulates an early-response gene containing homology to platelet proteins

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

IFNα and its response proteins, IP-10 and SIGLEC-1, are biomarkers of disease activity in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Reduced levels of CCL2 and CXCL10 in systemic lupus erythematosus patients under treatment with prednisone, mycophenolate mofetil, or hydroxychloroquine, except in a high STAT1 subset.

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

SERUM LEVELS OF IFN-INDUCIBLE PROTEIN-10 RELATING TO THE ACTIVITY OF SYSTEMIC LUPUS ERYTHEMATOSUS

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

Enhanced expression of interferon-inducible protein-10 correlates with disease activity and clinical manifestations in systemic lupus erythematosus

1 reference

https://api.crossref.org/works/10.1007%2FS11095-014-1492-2

21 January 2018

IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Up-regulated MHC-class II expression and gamma-IFN and soluble IL-2R in lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Upregulation of lymphoid and renal interferon-gamma mRNA in autoimmune MRL-Fas(lpr) mice with lupus nephritis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genetics of systemic autoimmunity and glomerulonephritis in mouse models of lupus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant interleukin 2 toxicity, pharmacokinetics, and immunomodulatory effects in a phase I trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetics and leukocyte responses of recombinant human interleukin-10

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Levels of IL-12 in the sera of patients with systemic lupus erythematosus (SLE)--relation to Th1- and Th2-derived cytokines

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dynamic alteration of soluble serum biomarkers in healthy aging

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic study of partially pure gamma-interferon in cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The regulation of inflammation by interferons and their STATs

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Serum level of interferon-gamma in autoimmune diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Population pharmacokinetic meta-analysis of denosumab in healthy subjects and postmenopausal women with osteopenia or osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interferon-γ polymorphisms in systemic lupus erythematosus

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Enhanced interferon-gamma (IFN) production by lymph node cells from autoimmune (MRL/1, MRL/n) mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Monoclonal antibody pharmacokinetics and pharmacodynamics

1 reference

https://pubmed.ncbi.nlm.nih.gov/25213774

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11095-014-1492-2

1 reference

Europe PubMed Central

9 September 2017

1 reference

Europe PubMed Central

9 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39130536&oldid=2143943248"